Lasers may play a pivotal role in the treatment of neurological diseases like Parkinson’s and Alzheimer's, according to research recently reported on The Verge.
In the study, researchers discovered that it was possible to distinguish protein aggregations through the use of a multiphoton laser. Certain protein aggregations are associated with an increased risk of Alzheimer’s disease.
Researchers at the Polish Wroclaw University of Technology and Chalmers University of Technology found that it possible to distinguish protein aggregations through the use of a multiphoton laser. Certain protein aggregations are associated with an increased risk of Alzheimer’s disease.
"We have found a totally new way of discovering these structures using just laser light,” noted Piotr Hanczyc, a researcher at Chalmers. "Nobody has talked about using only light to treat these diseases until now."
While distinguishing these protein aggregations is an important first step, this process wouldn’t be able to treat brain diseases on its own. However, researchers believe that photoacoustic therapy might be an effective way to break down these aggregated proteins. Mad cow disease (also known as Creutzfeldt-Jacob disease) could also be treated with this novel technology.
The photoacoustic effect involves the formation of sound waves following light absorption in a material sample.
- How to Develop a Risk Based Biological Safety Evaluation Per New US FDA Guidance - Webcast
- 3 Tips for Successfully Launching an Outsourced Medical Device - Webcast
- When Do I Really Need to Perform an Ethylene Oxide Requalification? - Webcast
- Rapid Prototyping for Medical Devices - Webcast
- New Approaches to Assessing Biocompatibility for Medical Devices - Webcast
- Five Mistakes That Can Derail Your Product Development Effort - Webcast